Cytokinetics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytokinetics and other ETFs, options, and stocks.

About CYTK

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.

CEO

Robert I. Blum

CEORobert I. Blum

Employees

423

Employees423

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

1997

Founded1997

Employees

423

Employees423

CYTK Key Statistics

Market cap

6.82B

Market cap6.82B

Price-Earnings ratio

-11.80

Price-Earnings ratio-11.80

Dividend yield

—

Dividend yield—

Average volume

1.24M

Average volume1.24M

High today

$66.61

High today$66.61

Low today

$65.00

Low today$65.00

Open price

$66.08

Open price$66.08

Volume

900.18K

Volume900.18K

52 Week high

$110.25

52 Week high$110.25

52 Week low

$25.98

52 Week low$25.98

CYTK News

Yahoo Finance 1d

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c) - Yahoo Finance

Cytokinetics, Incorporated SOUTH SAN FRANCISCO, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on Apri...

Benzinga 2d

Analyzing Cytokinetics's Short Interest - Cytokinetics - Benzinga

Loading... Loading... Cytokinetics's CYTK short percent of float has fallen 11.8% since its last report. The company recently reported that it has 13.23 millio...

Yahoo Finance 2d

Cytokinetics May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance

Cytokinetics (CYTK) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended March 2024. Thi...

Analyst ratings

88%

of 17 ratings

Buy

88.2%

Hold

11.8%

Sell

More CYTK News

Yahoo Finance 4d

Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the ... - Yahoo Finance

Cytokinetics, Incorporated SOUTH SAN FRANCISCO, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced it will ho...